The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

According to the National Kidney Foundation, 123,000 Americans are on that waitlist. More than a 100,000 of those waiting ...

The WHO released a set of guidelines on Sunday recommending the use of lower-sodium salt substitutes, essentially including ...

This week the World Health Organization (WHO) released new guidelines recommending people switch the regular salt they use at ...

Heart disease is closely linked with obesity. Excess weight mainly accounts for the surge in deaths from cardiovascular ...

Sixteen-year-old Colette Nwachukwu is appealing for financial assistance to undergo surgery after being diagnosed with advanced ...